SPL 2.11% 9.3¢ starpharma holdings limited

Ann: Starpharma signs new DEP partnership with Chase Sun, page-39

  1. 2,255 Posts.
    lightbulb Created with Sketch. 325
    Almost 48hrs and not one post.......things really are quiet in here

    I have asked the company the question (and still have not received a reply) but I wonder whether anyone in here can confirm for me?

    With the DEP DOX Trail it stared out as a monotherapy trail and it then evolved into a trail with multiple arms using combinations of DEP.

    My question is, when the results for the original monotherapy arm are complete does the company have to release them? Like they said they would be in 1HY2020??? Or will they hold onto all results and release the whole lot at once?

    I am concerned because if they are holding back on releasing the monotherapy results is it because they are not good?


 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.